Healthtech startup Axmed, led by Nigerian CEO Emmanuel Akpakwu, has secured $2 million in seed funding from Founderful Ventures. This follows a $5 million grant from the Bill and Melinda Gates Foundation for improving maternal and child healthcare in priority countries.
Stay well-informed and be the very first to receive all the most recent updates directly in your email! Tap here to join now for free!
Headquartered in Switzerland, Axmed aims to provide high-quality drugs to underserved nations. Akpakwu, drawing from his Nigerian upbringing, plans to launch a pioneering product to address medical supply chain challenges and improve access to essential medicines.
Axmed’s founding team, including Emmanuel Akpakwu, Felix Ohnmacht, and Sofia Radley-Searle, brings a wealth of experience from the pharmaceutical and healthcare sectors.
Initially targeting markets in Nigeria, Kenya, Ethiopia, Tanzania, and Rwanda, Axmed plans to leverage partnerships with faith-based organizations, NGOs, and government agencies to expand its reach. Beyond improving supply chain efficiency, Axmed aims to create a more equitable pharmaceutical market, ensuring that all countries, regardless of size or wealth, have access to life-saving medications at affordable prices.
With a mission to transform healthcare delivery in underserved regions, Axmed represents a beacon of hope for millions worldwide. By harnessing technology and fostering collaboration between stakeholders, Axmed endeavors to revolutionize the way essential medicines are sourced and distributed, ultimately saving lives and improving health outcomes for vulnerable populations.
Stay well-informed and be the very first to receive all the most recent updates directly in your email! Tap here to join now for free!
